A Brief Review on Therapeutic Potential of Nanocarrier Systems Against Breast Cancer | Abstract
Journal of Biomolecular Research & Therapeutics

Journal of Biomolecular Research & Therapeutics
Open Access

ISSN: 2167-7956



A Brief Review on Therapeutic Potential of Nanocarrier Systems Against Breast Cancer

Swarupananda M*, Saumyakanti G, Subhasis M and Bijaya G

Now a day’s breast cancer is one of the major type of non-cutaneous cancer occurred in female bodies. There are many approaches to treat this type of cancer, but significant treatments for breast cancer are truly limited. Not only the existing treatments are very low in number, but they have number of toxicity issues also. That is why now nano carrier based approaches are under the spot light and researchers are trying to explore this novel area of treatment for breast cancer. The success of any anticancer chemotherapy truly depends on the ability of the drug to reach their targeted body site, where the abnormal cell growth has occurred. Conventional types of treatment has no such targeting benefits. The nanocarriers based drug delivery systems are having some great advantages. These carrier systems have great specific targeting ability; they can modify the bio-distributionand pharmacokinetic profiles of the therapeutic agents. That is why nanocarriers are having lesser cytotoxic side effects than the conventional type of treatments. And these benefits make these carrier systems unique. The popular nanocarries used for today are liposomes, carbon nanotubes, micelles, quantum dots, nanoparticles, gold nanoparticles, solid lipid nanoparticles etc. This review is a brief discussion about the nanocarriers used for breast cancer today and their advancements.

Published Date: 2019-03-20; Received Date: 2019-02-01